Whitepaper and App Notes

Simoa® for Early Detection of Blood-Based Biomarkers Associated with Alzheimer’s Disease


App Note

Alzheimer’s disease (AD) is a devastating illness that affects tens of millions of people worldwide (1). In addition to the emotional and financial burden on patients and caregivers, deaths from AD have increased by 145% between 2000 and 2019 (1). This highlights the urgent need for more efficient detection, monitoring, and treatment methods. Early detection and accurate diagnosis of AD is crucial to developing treatments, improving patient outcomes, and finding a cure. Download our app note to learn more.